Vaxcyte, Inc. (NASDAQ:PCVX) has 287 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 290,400 | 2.92% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 1,324,581 | 10.59% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 9,663,714 | 116.22% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -307,472 | -50.93% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 282,985 | 2.16% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | 283,265 | 7.48% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | -35,029 | -69.19% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -126,467 | -1.03% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | 1,000,000 | 33.33% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,173 | 143.57% | $0.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 0 | -1,241,392 | -10.37% | $0.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 0 | -149,253 | -4.86% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 933,539 | 18.55% | $0.00 |
| Caligan Partners LP | 31 Dec, 2025 | 0 | 1,704,815 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 194,116 | 4.06% | $0.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 0 | 1,257,253 | 302.57% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | -659,737 | -15.38% | $0.00 |
| Pivotal bioVenture Partners Investment Advisor LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 31 Dec, 2025 | 0 | -192,998 | -5.17% | $0.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 0 | -224,261 | -15.77% | $0.00 |